Vopratelimab
Vopratelimab Uses, Dosage, Side Effects, Food Interaction and all others data.
Vopratelimab is under investigation in clinical trial NCT02904226 (JTX-2011 Alone and in Combination With Anti-PD-1 or Anti-CTLA-4 in Subjects With Advanced and/or Refractory Solid Tumors).
Trade Name | Vopratelimab |
Generic | Vopratelimab |
Vopratelimab Other Names | Vopratelimab |
Type | |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Vopratelimab